|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Engstrand J, Nilsson H, Stromberg C, Jonas
E and Freedman J: Colorectal cancer liver metastases-a
population-based study on incidence, management and survival. BMC
Cancer. 18:782018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mahasneh A, Al-Shaheri F and Jamal E:
Molecular biomarkers for an early diagnosis, effective treatment
and prognosis of colorectal cancer: Current updates. Exp Mol
Pathol. 102:475–483. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Symonds EL, Pedersen S, Cole SR, Massolino
J, Byrne D, Guy J, Backhouse P, Fraser RJ, LaPointe L and Young GP:
Improving participation in colorectal cancer screening: A
randomised controlled trial of sequential offers of faecal then
blood based non-invasive tests. Asian Pac J Cancer Prev.
16:8455–8460. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka S: Molecular pathogenesis and
targeted therapy of pancreatic cancer. Ann Surg Oncol. 23 (Suppl
2):S197–S205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li XL, Zhou J, Chen ZR and Chng WJ: P53
mutations in colorectal cancer-molecular pathogenesis and
pharmacological reactivation. World J Gastroenterol. 21:84–93.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Heinemann V, Douillard JY, Ducreux M and
Peeters M: Targeted therapy in metastatic colorectal cancer-an
example of personalised medicine in action. Cancer Treat Rev.
39:592–601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lalevee S and Feil R: Long noncoding RNAs
in human disease: Emerging mechanisms and therapeutic strategies.
Epigenomics. 7:877–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arun G, Diermeier SD and Spector DL:
Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol
Med. 24:257–277. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Z, Wu P, Su M, Ling H, Khoshaba R,
Huang C, Gao H, Zhao Y, Chen J, Liao Q, et al: Long non-coding RNA
UASR1 promotes proliferation and migration of breast cancer cells
through the AKT/mTOR pathway. J Cancer. 10:2025–2034. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang W, Wang Z, Wang H, Li X and Wang HT:
Promoting effect of PAX5-activated lncRNA UASR1 on growth of
colorectal cancer by regulating the mTOR pathway. Eur Rev Med
Pharmacol Sci. 24:2986–2993. 2020.PubMed/NCBI
|
|
15
|
Li XY, Luo QF, Wei CK, Li DF, Li J and
Fang L: miRNA-107 inhibits proliferation and migration by targeting
CDK8 in breast cancer. Int J Clin Exp Med. 7:32–40. 2014.PubMed/NCBI
|
|
16
|
Weiser MR: AJCC 8th edition: Colorectal
cancer. Ann Surg Oncol. 25:1454–1455. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benson AB III, Bekaii-Saab T, Chan E, Chen
YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton
MJ, et al: Metastatic colon cancer, version 3.2013: Featured
updates to the NCCN guidelines. J Natl Compr Canc Netw. 11:141–152.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu C, Xie Z and Peng Q: miRNA-107 enhances
chemosensitivity to paclitaxel by targeting antiapoptotic factor
Bcl-w in non small cell lung cancer. Am J Cancer Res. 7:1863–1873.
2017.PubMed/NCBI
|
|
20
|
Chen L, Zhang R, Li P, Liu Y, Qin K, Fa
ZQ, Liu YJ, Ke YQ and Jiang XD: P53-induced microRNA-107 inhibits
proliferation of glioma cells and down-regulates the expression of
CDK6 and Notch-2. Neurosci Lett. 534:327–332. 2013. View Article : Google Scholar : PubMed/NCBI
|
